Dual Targeting of Integrin αvβ3 and VEGF Receptor Improves PET Imaging of Breast Cancer

Résumé fourni par la source

Abstract Background: Neuropilin-1 (NRP-1) and integrin αvβ3 receptors are both overexpressed in breast cancer. Methods: We developed and synthesized a heterodimeric tracer consisting of Arg−Gly−Asp (RGD) and Ala-Thr-Trp-Leu-Pro-Pro-Arg (ATWLPPR) peptides that simultaneously targets integrin αvβ3 and NRP-1. We then investigated the diagnostic efficacy of RGD-ATWLPPR heterodimeric peptides in MCF-7 xenograft models in mice. DOTA-conjugated RGD-ATWLPPR peptides were then radiolabeled with 68Ga, and the receptor-binding characteristics and tumor-targeting efficacy of 68Ga-DOTA-RGD-ATWLPPR were investigated in vitro and in vivo. We also detected integrin αvβ3 and NRP-1 expression in MCF-7 cells and tumor tissues. Results: The peptide showed high stability in vitro. Static PET/CT imaging studies showed that MCF-7 tumors were clearly visible 30 min and 60 min after 68Ga-DOTA-RGD-ATWLPPR injection. Further, the heterodimer showed higher tumor uptake than 68Ga-DOTA-RGD or 68Ga-DOTA-ATWLPPR alone. High specificity was shown in blocking studies using RGD and ATWLPPR peptides. MicroPET/CT and biodistribution studies using 68Ga-DOTA-RGD-ATWLPPR showed that the tracer specifically targets NRP-1 and integrin ανβ3 receptors. Conclusions: Compared with 68Ga-DOTA-RGD and 68Ga-DOTA-ATWLPPR, 68Ga-DOTA-RGD-ATWLPPR has higher binding affinity, better targeting efficiency, and longer tumor retention time. It therefore has potential as an imaging probe for breast cancer detection.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.